What is it?
Endogenous amino sulfonic acid
1Taurine is a sulfur-containing amino sulfonic acid rather than a protein-building amino acid. It occurs in human tissues and foods.
Human evidence has a narrow center of gravity
4Randomized-trial meta-analyses cover cardiometabolic markers in specific adult study populations. These findings are not a general nootropic, heart-health, or performance promise for healthy buyers.
Names, aliases and forms
Potential effects and evidence map
Taurine has more human research on cardiometabolic markers than on direct nootropic outcomes. Recent randomized-trial meta-analyses report pooled differences in blood pressure, glucose, insulin-resistance markers, triglycerides, and related endpoints, with population-specific and multi-week study contexts. Training and reaction-time findings are harder to interpret because many studies include caffeine or energy-drink formulas. Direct focus, memory, inflammation, and broad heart-health marketing exceed the evidence for taurine alone.
Taurine-alone training-performance evidence is mixed; results from caffeine-plus-taurine or energy-drink formulas should not be assigned to taurine alone.
Direct focus or attention benefits are not established for standalone taurine in the product-comparison context.
Typical dosages and timing
The 2024 meta-analysis included trials from 0.5 to 6 g/day and 5 to 365 days. These trial exposures are study context, not an individual target or cycling instruction.
Timing & effect horizon
The cardiometabolic trials summarized in the 2024 review lasted from 5 to 365 days. A study window describes observation length, not an acute effect duration or a required cycle.
In a small study of eight healthy male volunteers, plasma taurine peaked at about 1.5 hours and the plasma elimination The time for blood levels to fall by half during the final elimination phase.Source was about 1.0 hour. Those pharmacokinetic values do not establish how long a subjective or training effect lasts.
Safety, side effects and risk profile
Randomized-trial meta-analyses report changes in blood-pressure and metabolic markers; study context matters for people already receiving prescribed care for those markers.
A review-based safety assessment found no systematic adverse-effect pattern up to 3 g/day in normal healthy adults; product-specific excipients can still affect tolerability.
Headache or dizziness reported around energy products cannot be assigned to taurine alone when caffeine, exertion, heat, or fasting also differ.
The cited safety review is limited to normal healthy adults and does not establish safety of supplemental taurine during pregnancy or lactation.
Human evidence is stronger for selected cardiometabolic markers than for direct nootropic outcomes, and coformulated training studies limit attribution.
The cited EFSA source is a European energy-drink safety opinion, not a current worldwide legal classification for standalone supplements.
Legal and regulatory status
In the European Union, EFSA concluded in 2009 that taurine exposure from regular energy-drink consumption at the evaluated intake levels was not a safety concern. That opinion is not a current approval or legal classification for every standalone supplement, blend, claim, or jurisdiction.
Practical buying and quality notes
- For powder, compare price per gram and label-declared serving size. For capsules, compare declared taurine per capsule, total grams per bottle, excipients, and whether caffeine or other active ingredients are included.5
FAQ
Is Taurine a nootropic?
5Not as a strong direct focus or memory supplement. The more relevant human literature covers cardiometabolic markers and some training contexts, while direct cognition claims remain weak.
What dose did trials use?
3The 2024 meta-analysis includes trial doses from 0.5 to 6 g/day. Compare label-declared grams per serving and product context; trial exposure is not a personal dosing instruction.
How long do studies run?
3Cardiometabolic trials ranged from days to months. A subgroup finding after at least 8 weeks is a trial-context result, not a required cycle.
What should buyers compare first?
5Compare standalone taurine versus caffeine blends, label-declared grams per serving, price per gram, and whether stated claims match the evidence.
References
- PubChem Compound Summary for Taurine. National Center for Biotechnology Information.
- EFSA ANS Panel. The use of taurine and D-glucurono-gamma-lactone as constituents of the so-called energy drinks. EFSA Journal. 2009.
- Tzang CC, Chi LY, Lin LH, Lin TY, et al. Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Diabetes. 2024.
- Nie Z, Liu Y, Zhang M, Wu C, et al. Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials. Nutrition Reviews. 2025.
- Deng H, Wang L, Liu P, Naharudin MNB, et al. Caffeine and taurine: a systematic review and network meta-analysis of their individual and combined effects on physical capacity, cognitive function, and physiological markers. Journal of the International Society of Sports Nutrition. 2025.
- Sun Q, Wang J, Wang H, Yu H, et al. Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. Nutrients. 2024.
- Ghandforoush-Sattari M, Mashayekhi S, Krishna CV, Thompson JP, Routledge PA. Pharmacokinetics of oral taurine in healthy volunteers. Journal of Amino Acids. 2010.
- Shao A, Hathcock JN. Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regulatory Toxicology and Pharmacology. 2008;50(3):376-399.